Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase Signaling
Chen Liu(Novartis (Switzerland)), Huai‐Xiang Hao(Novartis (Switzerland))
Cited by 161
Related Papers
OPA1 downregulation is involved in sorafenib-induced apoptosis in hepatocellular carcinoma
|Laboratory Investigation|2012|83
A Synthetic Aptamer-Drug Adduct for Targeted Liver Cancer Therapy
|PLoS ONE|2015|82
Survivin Inhibition Is Critical for Bcl-2 Inhibitor-Induced Apoptosis in Hepatocellular Carcinoma Cells
|PLoS ONE|2011|48
AMPK blunts chronic heart failure by inhibiting autophagy
|Bioscience Reports|2018|46